Friday, June 19, 2020
Pre-Filled Syringes for Intravitreal Injection and Components Thereof
Elizabeth J. Holland
Goodwin Procter LLP
Novartis Pharma AG, Novartis Pharmaceuticals Corporation, and Novartis Technology LLC
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, regarding certain pre-filled syringes for intravitreal injection and components thereof. The proposed respondent is Regeneron Pharmaceuticals, Inc., Tarrytown, New York.